Influence of the Operative Day on the Average Duration of Stay in Primary Hip and Knee Replacements

NCT ID: NCT03132831

Last Updated: 2023-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1663 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-01

Study Completion Date

2018-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Reducing the length of stay (LOS) after primary arthroplasty is a relatively new target that arouses the attention of orthopedic surgeons in order to return home early through the fast recovery protocols but this goal is also wanted in public health for the sake of overall decline health spending in public costs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Reducing the length of stay (LOS) after primary arthroplasty is a relatively new target that arouses the attention of orthopedic surgeons in order to return home early through the fast recovery protocols but this goal is also wanted in public health for the sake of overall decline health spending in public costs.

Reducing the LOS after primary hip arthroplasty and knee is studied through many publications that found an LOS influenced by the own medical factors of patients (ref) However, no study to our knowledge research the influence of the operative day and the LOS.

For historical reasons, the organization of care is modified on the weekend (Saturday and Sunday) in particular by reducing the caregiver and also the lack of physical therapist to make the early postoperative get up (D0 or D1).

The hypothesis is that a patient operated the friday did not have the same care the first 48 hours that a patient who had surgery at the beggening of the week and that his recovery was therefore extended.

The investigator can also suppose that LOS was shorter for patients returning home for those who were transferred to a rehabilitation center or other structure.

The results will be adjusted according to the literature data on the age more than 80 years, sex, diabetes, cardiovascular diseases, respiratory diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Length of Stay Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Determine the DMS of the Total Hip Prosthesis of the University Hospital of Amiens (PTH) and the Total Knee Prosthesis (PTG)

To determine the DMS of the orthopedic department of the Amiens University Hospital after Total Hip Prosthesis (PTH) and First-line Total Knee Prosthesis (PTG) with its confidence interval and to compare it according to the patient's day of operation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All major patients operated at the University Hospital of Amiens between 1 January 2015 and 31 December 2016 for primary hip and knee arthroplasty

Exclusion Criteria

* All patients undergoing surgery for hip or knee surgery (reoperation).
* All patients undergoing total arthroplasty on fracture of the femoral neck from all causes.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens Picardie

Amiens, Picardie, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RNI2016-34 Pr Mertl

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.